Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Transfus Med ; 26(5): 349-354, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27634577

ABSTRACT

OBJECTIVES: To evaluate the clinical significance of GP. Mur antigen-negative blood selection for transfusion in patients with anti-'Mia ' records. BACKGROUND: The GP. Mur RBC phenotype is prevalent (7·3%) in Taiwan. Antibodies against GP. Mur (anti-'Mia ') are identified in 1·24% of our population, and anti-'Mia ' screening using GP. Mur RBC has been routine for Taiwan's blood banks. However, due to the lack of commercial antibodies, only cross-matching was used to prevent transfusion of GP. Mur-positive blood to patients with anti-'Mia ' in most hospitals. There is still a risk of GP. Mur-positive RBC exposure and subsequent anti-'Mia '-related transfusion reactions. METHODS: Since February 2014, GP. Mur antigen-negative RBCs identified by reaction with anti-'Mia '-positive serum were selected for blood recipients with anti-'Mia ' records. The transfusion reactions between January 2013 and January 2014 were compared with those that occurred between February 2014 and July 2015. RESULTS: The transfusion reaction rate was significantly higher in anti-'Mia '-positive blood recipients compared to total subjects receiving an RBC transfusion before GP. Mur-negative donor RBC selection. After antigen-negative RBC selection, the transfusion reaction frequency in subjects with anti-'Mia ' became similar to total blood recipients. IgG form anti-'Mia ' antibodies were present in all cases of probable anti-'Mia '-related transfusion reactions. The time required for anti-'Mia ' boosting after transfusion was around 4-21 days. CONCLUSION: Selection of GP. Mur-negative RBC for transfusion to patients with anti-'Mia ' records could decrease the rate of transfusion reaction and antibody boosting. This procedure should be incorporated into blood bank routines in areas where anti-'Mia ' is prevalent.


Subject(s)
Blood Donors , Blood Group Antigens/blood , Blood Grouping and Crossmatching/methods , Donor Selection/methods , Erythrocytes/metabolism , Glycophorins/metabolism , Isoantibodies/blood , Erythrocytes/cytology , Female , Humans , Male
2.
Eur J Neurol ; 21(5): 797-801, 2014 May.
Article in English | MEDLINE | ID: mdl-24629033

ABSTRACT

BACKGROUND AND PURPOSE: Anosognosia and neglect may coexist in stroke patients. Neglect patients often report poor quality of life (QOL), whereas patients suffering from other cognition disorders with poor insight report better QOL. This study investigates the relationship between anosognosia, neglect and QOL amongst stroke survivors. METHODS: Stroke survivors who met the criteria were used as a sampling pool. Sixty stroke patients were observed in this study, amongst whom 20 patients with anosognosia and neglect (A+N+), 20 patients with neglect but not anosognosia (A-N+) and 20 patients with neither anosognosia nor neglect (A-N-) were selected from the sampling pool based on demographic characteristics matched with the A+N+ group. A questionnaire (SS-QOL) was used to collect the QOL perceived by the stroke survivors. RESULTS: The perceived QOL of the A+N+ group was significantly better than those of the other groups, including the subscales of self-care, mobility, work/productivity, upper extremity, mood, family role and social role. However, the A+N+ group had poor balance level and more fall incidents were reported. CONCLUSION: The A+N+ group perceived better QOL but had more falls and poorer balance than the other groups. Health providers should work with caregivers aggressively in preventing accidents.


Subject(s)
Agnosia/etiology , Functional Laterality/physiology , Perceptual Disorders/etiology , Quality of Life , Stroke , Adult , Aged , Analysis of Variance , Cognition Disorders/diagnosis , Cognition Disorders/etiology , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Stroke/complications , Stroke/mortality , Stroke/psychology
3.
Scand J Rheumatol ; 43(2): 146-52, 2014.
Article in English | MEDLINE | ID: mdl-24295199

ABSTRACT

OBJECTIVES: An elevated interleukin (IL)-1ß response in peripheral blood mononuclear cells (PBMCs) has been observed in systemic juvenile idiopathic arthritis (sJIA), suggesting a role for inflammasomes in the pathogenesis of JIA. We aimed to determine whether genetic polymorphisms of the NLRP3 inflammasome components confer risk for oligoarticular and polyarticular JIA in a Taiwanese population. METHOD: A total of 118 JIA patients and 103 healthy controls were genotyped for rs4353135 OR2B11/NLRP3 and rs2043211 CARD8 polymorphisms. Clinical laboratory data and serum IL-1ß of JIA patients were evaluated by medical chart review and enzyme-linked immunosorbent assay (ELISA), respectively. The production of IL-17 in lymphocytes of different genotype carriers was measured using flow cytometry. RESULTS: The variant rs4353135 G allele carrier conferred increased risk for oligoarticular and polyarticular JIA. The G allele was also found to be associated with higher levels of clinical inflammatory markers. Moreover, G variant carriers enhanced the lymphocyte IL-17 response. The G/G genotype further increased the need for treatment with the tumour necrosis factor (TNF) inhibitor etanercept. CONCLUSIONS: Our data indicate that the rs4353135 OR2B11/NLRP3 polymorphism might be functional in, and could contribute to, the pathophysiology of oligoarticular and polyarticular JIA in a Taiwanese population.


Subject(s)
Arthritis, Juvenile/ethnology , Arthritis, Juvenile/genetics , CARD Signaling Adaptor Proteins/genetics , Carrier Proteins/genetics , Genetic Predisposition to Disease/ethnology , Genetic Predisposition to Disease/genetics , Neoplasm Proteins/genetics , Polymorphism, Single Nucleotide/genetics , Adolescent , Alleles , Arthritis, Juvenile/epidemiology , Case-Control Studies , Child , Child, Preschool , Etanercept , Female , Genetic Predisposition to Disease/epidemiology , Genotype , Homozygote , Humans , Immunoglobulin G/therapeutic use , Inflammasomes/physiology , Interleukin-17/metabolism , Interleukin-1beta/metabolism , Male , NLR Family, Pyrin Domain-Containing 3 Protein , Receptors, Tumor Necrosis Factor/therapeutic use , Taiwan/epidemiology , Tumor Necrosis Factor-alpha/antagonists & inhibitors
4.
Chest ; 114(1): 340-2, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9674495

ABSTRACT

Diagnosis and successful therapy for primary cutaneous zygomycosis (mucormycosis) that complicated the securing of an endotracheal tube with cloth tape. Primary cutaneous mucormycosis is a rare fungal infection noted most often in immunosuppressed individuals. Cloth tape, of the type commonly used to secure endotracheal tubes, often is contaminated with fungal spores. In the case reported here, cloth tape securing the endotracheal tube was the probable vector for transmission of zygomycosis to a moderately imunocompromised host. Rapid diagnosis and combined medical and surgical therapy resulted in a favorable outcome.


Subject(s)
Dermatomycoses/etiology , Facial Dermatoses/microbiology , Intubation, Intratracheal/adverse effects , Mucormycosis/etiology , Rhizopus , Adult , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Dermatomycoses/diagnosis , Dermatomycoses/drug therapy , Dermatomycoses/surgery , Disease Reservoirs , Equipment Contamination , Facial Dermatoses/diagnosis , Facial Dermatoses/drug therapy , Facial Dermatoses/surgery , Female , Follow-Up Studies , Humans , Immunocompromised Host , Lupus Erythematosus, Systemic/complications , Mucormycosis/diagnosis , Mucormycosis/drug therapy , Mucormycosis/surgery , Mucormycosis/transmission , Pneumonia, Pneumococcal/complications , Spores
SELECTION OF CITATIONS
SEARCH DETAIL
...